Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Systemic inflammation

Modelling systemic risk factors in cardiovascular disease using single-cell biology

The plasma of individuals with atherosclerosis contains cytokines that induce a pathogenic signaling cascade in immune cells. Saracatinib, a dual kinase inhibitor that targets the tyrosine kinases SRC and BCR-ABL, can prevent activation of this phospho-signaling pathway implicated in the pathogenesis of cardiovascular disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Atheroplasma induces a pathogenic tyrosine phosphorylation-dependent signaling cascade in myeloid cells in CVD.

References

  1. Bouabdallaoui, N. et al. Eur. Heart J. 41, 4092–4099 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ridker, P. M. et al. N. Engl. J. Med. 377, 1119–1131 (2017).

    Article  CAS  PubMed  Google Scholar 

  3. Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A. & Thompson, P. L. J. Am. Coll. Cardiol. 61, 404–410 (2013).

    Article  CAS  PubMed  Google Scholar 

  4. Oikonomou, E. K. et al. Lancet 392, 929–939 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kannel, W. B., McGee, D. & Gordon, T. Am. J. Cardiol. 38, 46–51 (1976).

    Article  CAS  PubMed  Google Scholar 

  6. Narula, J. et al. Nat. Clin. Pract. Cardiovasc. Med. 5, S2–10 (2008). Suppl 2.

    Article  PubMed  Google Scholar 

  7. Liuzzo, G. et al. N. Engl. J. Med. 331, 417–424 (1994).

    Article  CAS  PubMed  Google Scholar 

  8. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. & Hennekens, C. H. N. Engl. J. Med. 336, 973–979 (1997).

    Article  CAS  PubMed  Google Scholar 

  9. The Emerging Risk Factors Consortium. Lancet 375, 132–140 (2010).

    Article  Google Scholar 

  10. Amadori, L. et al. Nat. Cardiovas. Res. https://doi.org/10.1038/s44161-023-00278-y (2023).

    Article  Google Scholar 

  11. Blanco, P., Palucka, A. K., Gill, M., Pascual, V. & Banchereau, J. Science 294, 1540–1543 (2001).

    Article  CAS  PubMed  Google Scholar 

  12. Engelen, S. E., Robinson, A. J. B., Zurke, Y.-X. & Monaco, C. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-021-00668-4 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Full, L. E., Ruisanchez, C. & Monaco, C. Arthritis Res. Ther. 11, 217 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Stewart, C. R. et al. Nat. Immunol. 11, 155–161 (2010).

    Article  CAS  PubMed  Google Scholar 

  15. McCarey, D. W. et al. Lancet 363, 2015–2021 (2004).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claudia Monaco.

Ethics declarations

Competing interests

The authors have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Monaco, C., Dib, L. Modelling systemic risk factors in cardiovascular disease using single-cell biology. Nat Cardiovasc Res 2, 496–497 (2023). https://doi.org/10.1038/s44161-023-00285-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-023-00285-z

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research